Art
J-GLOBAL ID:201202254581734637   Reference number:12A1656096

Endpoints pertaining to survival time in clinical cancer research.

癌臨床研究における生存時間に関するエンドポイント
Author (10):
Material:
Volume: 75  Issue: 7/9  Page: 260-267  Publication year: Sep. 25, 2012 
JST Material Number: F0979B  ISSN: 0368-5810  CODEN: KIZAAL  Document type: Article
Article type: 原著論文  Country of issue: Japan (JPN)  Language: JAPANESE (JA)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=12A1656096&from=J-GLOBAL&jstjournalNo=F0979B") }}
JST classification (1):
JST classification
Category name(code) classified by JST.
Clinical oncology in general 
Reference (18):
  • 1) 折笠秀樹 : 医学研究における統計入門 (7) エンドポイント. 臨床麻酔 17:1343-1347, 1993
  • 2) 佐藤暁洋, 石塚直樹, 福田治彦 : 生存時間に関するエンドポイントについて—用語解説と若干の方法論的考察—癌と化学療法 30:1057-1064, 2003
  • 3) Punt CJ, Buyse M, Kane CH, Hohenberger P, Labianca R, Schmoll HJ, P allman L, Sobrero A, Douillard JY:Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials. J Natl Cancer Inst 99:998-1003, 2007
  • 4) Van Cutsem E, Labianca R, Bodoky G, Barone C, Aranda E, Nordlinger B, Topham C, Tabernero J, André T, Sobrero AF, Mini E, Greil R, Di Costanzo F, Collette L, Cisar L, Zhang X, Khayat D, Bokemeyer C, Roth AD, Cunningham D:Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3. J Clin Oncol 27:3117-3125, 2009
  • 5) Twelves C, Wong A, Nowacki MP, Abt M, Burris H 3rd, Carrato A, Cassidy J, Cervantes A, Fagerberg J, Georgoulias V, Husseini F, Jodrell D, Koralewski P, Kröning H, Maroun J, Marschner N, McKendrick J, Pawlicki M, Rosso R, Schiiller J, Seitz JF, Stabuc B, Tujakowski J, Van Hazel G, Zaluski J, Scheithauer W:Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 352:2696-2704, 2005
more...
Terms in the title (5):
Terms in the title
Keywords automatically extracted from the title.

Return to Previous Page